HOME >> BIOLOGY >> NEWS
UPMC Reports On New Liver Assist Device

rials in our patients," added George V. Mazariegos, M.D., assistant professor of surgery at the University of Pittsburgh Thomas E. Starzl Transplantation Institute.

The UPMC study presented results on an animal model of acute liver failure, comparing the performance of the Excorp device against standard treatment. The animals were divided into three treatment groups, one receiving standard intensive care attention, and the remaining two groups being placed on the bio-artificial liver assist device at either 16-18 hours or 24-26 hours after liver failure was initiated.

The report indicated survival times in the groups treated with the Excorp device could be extended. These results suggest that the bio-artificial liver assist device does in fact have a marked effect on the course of acute liver failure. The intercranial pressure also improved in the treated animals.

The anticipated phase I human trials of the device would have the primary aim of ensuring the safety of the device for human use. The researchers would monitor the clinical stability of patients, their neurological status, and development of infection. Researchers also hope to gain insight about the device's impact on treating liver failure, although a second trial would need to be conducted to thoroughly study its treatment efficacy.

"We are very encouraged by these preliminary findings," commented Dr. Mazariegos. "The need for some type of bridging device between liver recovery or transplantation is intense. This bio-artificial liver assist device may someday help the thousands of liver failure patients whose options are limited."

Acute liver failure can be caused by poisonous mushrooms, reactions to Tylenol toxicity, or as a result of a virus. There are currently more than 10,000 patients awaiting liver transplants in the United States. Less than five percent of the approximately
'"/>

Contact: Lisa Rossi
RossiL@a1.isd.upmc.edu
(412) 624-2607
University of Pittsburgh Medical Center
23-Apr-1998


Page: 1 2 3

Related biology news :

1. Reports of "weird life" almost stranger than fiction
2. Reports from special environmental health issue explore links to autoimmune diseases - diabetes, lupus, multiple scleroris and arthritis
3. Osiris Therapeutics Reports Key Findings in SCIENCE Verifying Existence of Adult Stem Cells
4. Abgenix Reports Encouraging Preclinical Results With ABX-EGF In Cancer Research
5. New England Journal Of Medicine Reports Calcium Supplements Help Prevent Polyp Recurrence; DMS Led Study
6. Duke Scientist Reports Advances In Gene Therapy For Heart Failure
7. North America Absorbing Carbon Dioxide At Surprisingly High Rate, Team Reports
8. University Of Pittsburgh Reports Novel Ways To Improve Transplant Acceptance At Transplantation Society Meeting
9. Cell Pathways Reports Extension Study Results Showing Ability Of FGN-1 To Prevent Formation Of Precancerous Colon Polyps
10. Reports Mesh To Clarify Proteins Importance For Cancer
11. Infant Dependency Drives Menopause, NSF-Supported Researcher Reports

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2018)... (PRWEB) , ... August 01, 2018 , ... ... staff NP, PA’s, RN’s, LPN’s, MA's and Administrative staff. , This full day ... all the biologics. The course will expose your staff to regenerative medicine procedures ...
(Date:7/31/2018)... ... July 31, 2018 , ... Lifecycle Biotechnologies, a leading life ... In this role, Mr. Muzek will lead the company-wide industrial strategic business development ... , With over 20 years in business development, Mr. Muzek previously served ...
(Date:7/28/2018)... ... 2018 , ... Inthirani Arul, an evidence-based healer, today announces research results based ... autoimmune disorders. , Biomarkers for immune function, blood, as well as, inflammation, were ... 110% increase in overall immunity as seen by the rise in antibody levels , ...
Breaking Biology News(10 mins):
(Date:7/24/2018)... , ... July 23, 2018 , ... ... a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, and immune ... function response assessed in the preclinical research were significantly reduced. Results are as ...
(Date:7/24/2018)... ... July 24, 2018 , ... On ... highly successful SmartTRAK platform. Not just a pretty face, SmartTRAK 3.0’s latest ... , SmartTRAK is the world’s first online and real-time data portal that ...
(Date:7/22/2018)... ... 19, 2018 , ... The Center for Advancing Innovation (CAI) ... the Laura and John Arnold Foundation and MedImmune. The overarching goal of this ... 55 institutions, including the National Institutes of Health, the United States Army, and ...
(Date:10/13/2017)... OF PRUSSIA, PA (PRWEB) , ... October 13, 2017 , ... ... Vice President and Turesol Business Unit Leader, will moderate a discussion on the subject ... year’s ISPE Annual Meeting & Expo . The theme of this year’s meeting ...
Breaking Biology Technology:
Cached News: